Post date January 11, 2023 Experience Sirio Pharma acquisition of a majority stake of Best Formulations We advised Sirio Pharma on the acquisition
Post date November 17, 2022 Experience KOITO $100 million investment in Cepton We are advising KOITO on its investment in convertible preferred stock
Post date September 8, 2022 Experience Tencent €300 million investment in Ubisoft We are advising Tencent on the transaction
Post date August 19, 2022 Experience Esco Aster spinoff transactions We are advising Esco Lifesciences on the spinoff
Post date August 11, 2022 Experience InSilico Medicine $35 million Series D2 financing We are advising InSilico Medicine on the financing
Post date August 3, 2022 Experience Taibang Biologic Group $300 million equity raising We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
Post date June 29, 2022 Experience Tencent renewed strategic cooperation with JD.com We are advising Tencent on the renewal of the strategic cooperation agreement and purchase of ordinary shares of JD.com
Post date June 7, 2022 Experience InSilico Medicine $60 million Series D financing We are advising InSilico Medicine in connection with its $60 million Series D financing
Post date May 9, 2022 Experience Relo Group combination of BGRS and SIRVA We are advising Relo Group on the business combination of BGRS with SIRVA
Post date March 23, 2022 Experience Jeeves $180 million Series C equity financing round We advised Tencent as lead investor in the new round